Literature DB >> 19453710

Impaired function of GABA(B) receptors in tissues from pharmacoresistant epilepsy patients.

Laura A Teichgräber1, Thomas-Nicolas Lehmann, Heinz-Joachim Meencke, Torsten Weiss, Robert Nitsch, Rudolf A Deisz.   

Abstract

PURPOSE: Effects of pre- and postsynaptic γ-aminobutyric acid B (GABA(B)) receptor activation were characterized in human tissue from epilepsy surgery.
METHODS: Slices of human cortical tissue were investigated in a submerged-type chamber with intracellular recordings in layers II/III. Parallel experiments were performed in rat neocortical slices with identical methods. Synaptic responses were elicited with single or paired stimulations of incrementing intervals.
RESULTS: Neurons in human epileptogenic tissue exhibited usually small inhibitory postsynaptic potentials (IPSP) mediated by GABA(B) receptor, verified by the sensitivity to the selective antagonist CGP 55845A. The IPSP(B) conductance averaged 5.8 nS in neurons from epileptogenic tissues and 15.9 nS in neurons from nonepileptogenic tissues (p < 0.0001). Application of baclofen caused small conductance increases in human neurons, which were linearly related to IPSP(B) conductances. Paired-pulse stimulation revealed constant synaptic responses in human temporal lobe epilepsy (TLE) slices at all interstimulus intervals (ISIs). Pharmacologically isolated IPSP(A) in the human tissue exhibited a small paired-pulse depression (average 10% at 500 ms ISI). Bicuculline-induced paroxysmal depolarization shifts (PDSs) were transiently depressed by 24% in human TLE tissue; and by 74% in rat neocortical slices (200 ms ISI; p = 0.015). The depressions of bicuculline-induced PDSs were antagonized by CGP 55845A in both species. Staining for GABA(B) receptors revealed significantly smaller numbers of immunopositive dots in human epileptogenic neurons versus human control neurons. DISCUSSION: The small IPSP(B), baclofen-conductances, and paired-pulse depression of PDSs and IPSPs in human TLE tissue indicate a reduced density of post- and presynaptic GABA(B) receptors. The reduced efficacy of presynaptic GABA(B) receptors facilitates the occurrence of repetitive synaptic activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19453710     DOI: 10.1111/j.1528-1167.2009.02094.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  Components of neuronal chloride transport in rat and human neocortex.

Authors:  Rudolf A Deisz; Thomas-N Lehmann; Peter Horn; Christoph Dehnicke; Robert Nitsch
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

2.  Different pharmacology of N-desmethylclozapine at human and rat M2 and M 4 mAChRs in neocortex.

Authors:  S Gigout; S Wierschke; C Dehnicke; R A Deisz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-16       Impact factor: 3.000

3.  The Association Between STX1B Polymorphisms and Treatment Response in Patients With Epilepsy.

Authors:  Shitao Wang; Liang Zhou; Chenglu He; Dan Wang; Xuemei Cai; Yanying Yu; Liling Chen; Di Lu; Ligong Bian; Sunbing Du; Qian Wu; Yanbing Han
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

4.  Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex.

Authors:  Sylvain Gigout; Gareth A Jones; Stephan Wierschke; Ceri H Davies; Jeannette M Watson; Rudolf A Deisz
Journal:  BMC Neurosci       Date:  2012-04-27       Impact factor: 3.288

Review 5.  Keeping the Balance: GABAB Receptors in the Developing Brain and Beyond.

Authors:  Davide Bassetti
Journal:  Brain Sci       Date:  2022-03-22

6.  Regulating hippocampal hyperexcitability through GABAB Receptors.

Authors:  Min Lang; Homeira Moradi-Chameh; Tariq Zahid; Jonathan Gane; Chiping Wu; Taufik Valiante; Liang Zhang
Journal:  Physiol Rep       Date:  2014-04-22

7.  GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors.

Authors:  Luisa Rocha; Mario Alonso-Vanegas; Iris E Martínez-Juárez; Sandra Orozco-Suárez; David Escalante-Santiago; Iris Angélica Feria-Romero; Cecilia Zavala-Tecuapetla; José Miguel Cisneros-Franco; Ricardo Masao Buentello-García; Jesús Cienfuegos
Journal:  Front Cell Neurosci       Date:  2015-01-05       Impact factor: 5.505

Review 8.  Synaptic Reshaping and Neuronal Outcomes in the Temporal Lobe Epilepsy.

Authors:  Elisa Ren; Giulia Curia
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

9.  GABAB Receptors in Neurodegeneration.

Authors:  Alessandra P Princivalle
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 10.  GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators.

Authors:  A Nieto; T Bailey; K Kaczanowska; P McDonald
Journal:  Curr Top Behav Neurosci       Date:  2022
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.